Client News
Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
27th September 2023
Destiny Pharma: Destiny Pharma: Notice of XF Pipeline Update Meeting
27th September 2023
Destiny Pharma: Interim results for the six months ended 30 June 2023
20th September 2023
Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
20th September 2023
Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer
19th September 2023
Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology
18th September 2023
Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Library
18th September 2023
Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities
13th September 2023
Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis
13th September 2023
There is no more content to load